FUNCTION OF THE C-MYC ONCOPROTEIN

被引:163
作者
KATO, GJ
DANG, CV
机构
[1] JOHNS HOPKINS UNIV, SCH MED,DEPT MED,1012 ROSS RES BLDG, 720 RUTLAND AVE, BALTIMORE, MD 21205 USA
[2] JOHNS HOPKINS UNIV, SCH MED, DEPT PEDIAT, DIV HEMATOL, BALTIMORE, MD 21205 USA
[3] JOHNS HOPKINS UNIV, SCH MED, DEPT CELL BIOL & ANAT, BALTIMORE, MD 21205 USA
[4] JOHNS HOPKINS UNIV, SCH MED, JOHNS HOPKINS ONCOL CTR, BALTIMORE, MD 21205 USA
关键词
HELIX-LOOP-HELIX; LEUCINE ZIPPER; NUCLEAR LOCALIZATION SIGNAL; TRANSCRIPTIONAL ACTIVATION; MAX; DNA BINDING; TRANSCRIPTION FACTOR; ONCOGENES;
D O I
10.1096/fasebj.6.12.1521738
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The c-Myc protein, the product of the c-myc proto-oncogene, is a nuclear phosphoprotein with DNA binding properties. Deregulated c-myc expression participates in the development of experimentally induced tumors, and its expression appears to be abnormal in many naturally occurring malignancies. Although the precise molecular mechanism of c-Myc activity in oncogenesis and in normal cell proliferation is unknown, recent advances have uncovered a series of molecular and cellular properties of c-Myc. These properties include nuclear localization, transcriptional activation, oligomerization, nonspecific and specific DNA binding. Recently, the c-Myc protein was found to heterodimerize with Max, a protein that cooperates with c-Myc to bind specifically to a core DNA sequence, CAC(G/A)TG. These characteristics suggest that c-Myc participates in the regulation of gene transcription in normal and neoplastic cells.
引用
收藏
页码:3065 / 3072
页数:8
相关论文
共 97 条
[1]   THE C-MYC ONCOGENE DRIVEN BY IMMUNOGLOBULIN ENHANCERS INDUCES LYMPHOID MALIGNANCY IN TRANSGENIC MICE [J].
ADAMS, JM ;
HARRIS, AW ;
PINKERT, CA ;
CORCORAN, LM ;
ALEXANDER, WS ;
CORY, S ;
PALMITER, RD ;
BRINSTER, RL .
NATURE, 1985, 318 (6046) :533-538
[2]   HOMOGENEOUSLY STAINING CHROMOSOMAL REGIONS CONTAIN AMPLIFIED COPIES OF AN ABUNDANTLY EXPRESSED CELLULAR ONCOGENE (C-MYC) IN MALIGNANT NEUROENDOCRINE CELLS FROM A HUMAN-COLON CARCINOMA [J].
ALITALO, K ;
SCHWAB, M ;
LIN, CC ;
VARMUS, HE ;
BISHOP, JM .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA-BIOLOGICAL SCIENCES, 1983, 80 (06) :1707-1711
[3]   MYC-ONCOGENES - ACTIVATION AND AMPLIFICATION [J].
ALITALO, K ;
KOSKINEN, P ;
MAKELA, TP ;
SAKSELA, K ;
SISTONEN, L ;
WINQVIST, R .
BIOCHIMICA ET BIOPHYSICA ACTA, 1987, 907 (01) :1-32
[4]   MOLECULAR CHARACTERIZATION OF HELIX-LOOP-HELIX PEPTIDES [J].
ANTHONYCAHILL, SJ ;
BENFIELD, PA ;
FAIRMAN, R ;
WASSERMAN, ZR ;
BRENNER, SL ;
STAFFORD, WF ;
ALTENBACH, C ;
HUBBELL, WL ;
DEGRADO, WF .
SCIENCE, 1992, 255 (5047) :979-983
[5]   CLONING AND NUCLEOTIDE-SEQUENCE OF THE CHIMPANZEE C-MYC GENE [J].
ARGAUT, C ;
RIGOLET, M ;
ELADARI, ME ;
GALIBERT, F .
GENE, 1991, 97 (02) :231-237
[6]   THE LEUCINE ZIPPER OF TFE3 DICTATES HELIX LOOP HELIX DIMERIZATION SPECIFICITY [J].
BECKMANN, H ;
KADESCH, T .
GENES & DEVELOPMENT, 1991, 5 (06) :1057-1066
[7]   CASEIN KINASE-II INHIBITS THE DNA-BINDING ACTIVITY OF MAX HOMODIMERS BUT NOT MYC MAX HETERODIMERS [J].
BERBERICH, SJ ;
COLE, MD .
GENES & DEVELOPMENT, 1992, 6 (02) :166-176
[8]   MOLECULAR THEMES IN ONCOGENESIS [J].
BISHOP, JM .
CELL, 1991, 64 (02) :235-248
[9]   SEQUENCE-SPECIFIC DNA-BINDING BY THE C-MYC PROTEIN [J].
BLACKWELL, TK ;
KRETZNER, L ;
BLACKWOOD, EM ;
EISENMAN, RN ;
WEINTRAUB, H .
SCIENCE, 1990, 250 (4984) :1149-1151
[10]   MYC AND MAX ASSOCIATE INVIVO [J].
BLACKWOOD, EM ;
LUSCHER, B ;
EISENMAN, RN .
GENES & DEVELOPMENT, 1992, 6 (01) :71-80